Integrating Combined Therapies for Persons With Co-occurring Disorders
ICT
1 other identifier
interventional
38
1 country
1
Brief Summary
The purpose of this study is to assess the effectiveness and implementability of ICT for co-occurring alcohol use and mental health disorders within community addiction treatment, as delivered by routine community addiction clinicians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 27, 2015
CompletedFirst Posted
Study publicly available on registry
November 6, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedJune 29, 2018
June 1, 2018
2.3 years
October 27, 2015
June 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Decrease from baseline in alcohol use (90-day Timeline Follow Back (TLFB) at 4-months and at 7-months
Baseline, 4-month, 7-month follow-up
Decrease from baseline in alcohol use severity (ASI; alcohol severity composite) at 4-months and at 7-months
Baseline, 4-month, 7-month follow-up
Decrease from baseline in alcohol use severity (Short Inventory of Problems (SIP)) at 4-months and at 7-months
Baseline, 4-month, 7-month follow-up
Decrease from baseline in psychiatric symptom severity (ASI; Psychiatric Severity Composite) at 4-months and at 7-months
Baseline, 4-month, 7-month follow-up
Decrease in psychiatric symptom severity (Brief Symptom Inventory (BSI)) at 4-months and 7-months
Baseline, 4-month, 7-month follow-up
Secondary Outcomes (3)
Decrease from baseline in drug use (90-day TLFB) at 4-months and at 7-months
Baseline, 4-month, 7-month follow-up
Decrease from baseline in positive toxicology screen (urine drug screen) at 4-months and at 7-months
Baseline, 4-month, 7-month follow-up
Decrease from baseline in drug use severity (ASI; Drug Severity Composite) at 4-months and 7-months
Baseline, 4-month, 7-month follow-up
Study Arms (2)
Integrating Combined Therapies
EXPERIMENTALIntegrating Combined Therapies (ICT) is a 10-session, manual-guided individual therapy. ICT has three phases designed to address substance use, psychiatric problems and their interactions. MET is the first phase (2 sessions) and is focused on assessment, feedback and securing motivation to address problems and take steps. CBT is the second phase (5 sessions) and incorporates patient education and functional analysis, develops coping skills, teaches methods to challenge beliefs, and activates alternative behaviors. TSF (3 sessions) is focused on maintaining recovery and engaging in community-based recovery activities. Although ICT has core components, its application is flexible to accommodate the unique needs and problems of individual patients (and their comorbidities).
Standard Care
ACTIVE COMPARATORStandard Care (SC) is the typical outpatient treatment that the patient would receive ordinarily at the identified addiction treatment program. SC service operates using the American Society of Addiction Medicine criteria (9 hours per week); group and individual sessions focused on motivation to address substance use, education about the consequences of substance use on major life areas, education about the disease concept and brain changes associated with addiction, exposure to information about social and family relationships and recovery, and relapse prevention skills.
Interventions
Individual Integrating Combined Therapies, approximately 10 sessions, one session per week
Standard Care, individual or group therapy, approximately 9 hours per week for 3 months.
Eligibility Criteria
You may qualify if:
- At least 18 years old;
- Evaluated and admitted to outpatient addiction treatment services at RMHS Evergreen program and meets criteria for any alcohol or substance use disorder;
- Screened positive for an alcohol problem on the Alcohol Use Disorders Identification Test (AUDIT) (score of 8 or higher) (screening instrument);
- Screened positive for a mental health problem on the Modified MINI Screen (MMS) (score of 6 or higher) (screening instrument);
- Diagnoses confirmed by SCID (diagnostic interview); AND
- Willing and able to provide informed consent.
You may not qualify if:
- They have acute psychotic symptoms and are not appropriately connected with mental health services;
- They have had a psychiatric hospitalization or suicide attempt within the past month (however, if the hospitalization or attempt was directly related to substance intoxication or detoxification and the person is currently stable, they are eligible); OR
- They have unstable medical or legal situations that would make participation for the full duration of the study highly unlikely.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Evergreen - Rutland Mental Health
Rutland, Vermont, 05701, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark P. McGovern, Ph.D.
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study Principal Investigator
Study Record Dates
First Submitted
October 27, 2015
First Posted
November 6, 2015
Study Start
July 1, 2015
Primary Completion
September 30, 2017
Study Completion
December 31, 2017
Last Updated
June 29, 2018
Record last verified: 2018-06